Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease-Reference-Cited by-同舟云学术

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

Published:2013-04 Issue:3 Volume:7 Page:213-221
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Schreiber S.,Reinisch W.,Colombel J.F.,Sandborn W.J.,Hommes D.W.,Robinson A.M.,Huang B.,Lomax K.G.,Pollack P.F.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/7/3/213/13071917/7-3-213.pdf

Reference32 articles.

1. Long-term evolution of disease behavior of Crohn's disease;Cosnes;Inflamm Bowel Dis,2002

2. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease;Louis;Gut,2001

3. Development of the Crohn's disease digestive damage score, the Lemann score;Pariente;Inflamm Bowel Dis,2011

4. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort;Thia;Gastroenterology,2010

5. Early Crohn disease: a proposed definition for use in disease-modification trials;Peyrin-Biroulet;Gut,2010

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IBD Diagnosis Delay and Its Predictors in Jordan: A Retrospective Study;JAP Academy Journal;2024-06-01

2. Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort;Gastroenterology;2024-05

3. FISTULIZING PERIANAL CROHN’S DISEASE: IS THE PATIENT’S SEX A BURDEN? A SYSTEMATIC REVIEW;Arquivos de Gastroenterologia;2023-11

4. Efficacy of IL-23 inhibitors and IL-12/23 inhibitors in the induction treatment of Crohn's disease: a meta-analysis based on randomized controlled trials;2023-09-05

5. Choosing the Right Therapy at the Right Time for Pediatric Inflammatory Bowel Disease;Gastroenterology Clinics of North America;2023-09